Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB)
Clinical trial NCT01300234 · COMPLETED
Trial details
- NCT number
- NCT01300234
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-30
- Primary completion
- 2012-10-17
- Enrollment
- 512
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.